BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sheikh-Taha M, Alaeddine S, Nassif J. Use of acid suppressive therapy in hospitalized non-critically ill patients. World J Gastrointest Pharmacol Ther 2012; 3(6): 93-96 [PMID: 23494814 DOI: 10.4292/wjgpt.v3.i6.93]
URL: https://www.wjgnet.com/2150-5349/full/v3/i6/93.htm
Number Citing Articles
1
Mega Octavia, Nurul Maziyyah, Rima Nurul Fauziyah. Appropriateness and Cost of Prophylaxis Stress Ulcer for Inpatient in the Internal Medicine Department in a Government Hospital: A Cross-Sectional StudyBorneo Journal of Pharmacy 2024; 7(1): 104 doi: 10.33084/bjop.v7i1.4080
2
Lama Soubra, Mohamed Issa. Prescribing of proton pump inhibitors for gastrointestinal bleeding prophylaxis in the Lebanese outpatient setting: patterns, compliance with guidelines and risksInternational Journal of Pharmacy Practice 2019; 27(4): 386 doi: 10.1111/ijpp.12537
3
R. Schepisi, Sergio Fusco, F. Sganga, B. Falcone, D.L. Vetrano, A. Abbatecola, F. Corica, M. Maggio, C. Ruggiero, P. Fabbietti, A. Corsonello, G. Onder, F. Lattanzio. Inappropriate use of proton pump inhibitors in elderly patients discharged from acute care hospitalsThe Journal of nutrition, health and aging 2016; 20(6): 665 doi: 10.1007/s12603-015-0642-5
4
Michael Yochelson, Amy Murphy. Traumatic Brain Injury Rehabilitation Medicine2015; : 118 doi: 10.2217/fmeb2013.13.318
5
Seyed Masoom Masoompour, Reza Kasaee, Hamideh Mahdaviazad. Evaluation of Adherence to American Society of Health-System Pharmacists GuidelinesGastroenterology Nursing 2017; 40(6): 491 doi: 10.1097/SGA.0000000000000278
6
Evence Daure, Linda Ross, Cynthia R. L. Webster. Gastroduodenal Ulceration in Small Animals: Part 2. Proton Pump Inhibitors and Histamine-2 Receptor AntagonistsJournal of the American Animal Hospital Association 2017; 53(1): 11 doi: 10.5326/JAAHA-MS-6634
7
Leon Fisher, Alexander Fisher. Acid-Suppressive Therapy and Risk of Infections: Pros and ConsClinical Drug Investigation 2017; 37(7): 587 doi: 10.1007/s40261-017-0519-y
8
Yousif A. Alosaily, Jawaher M. Alfallaj, Juman S. Alabduljabbar, Elham F. Alfehaid, Osamah M. Alfayez, Mohammedelbagir Elrasheed. Appropriateness of proton pump inhibitors use in noncritically ill hospitalized children in a tertiary hospital in Saudi ArabiaSaudi Pharmaceutical Journal 2023; 31(9): 101723 doi: 10.1016/j.jsps.2023.101723
9
Analysis of the use and cost of stress ulcer prophylaxis for surgical inpatientsJournal of Basic and Clinical Physiology and Pharmacology 2019; 30(6) doi: 10.1515/jbcpp-2019-0306
10
Daniel A Caroff, Deborah S Yokoe, Michael Klompas. Evolving Insights Into the Epidemiology and Control of Clostridium difficile in HospitalsClinical Infectious Diseases 2017; 65(7): 1232 doi: 10.1093/cid/cix456
11
Zhi-Kang Ye, Ying Liu, Xiang-Li Cui, Li-Hong Liu, John Green. Critical Appraisal of the Quality of Clinical Practice Guidelines for Stress Ulcer ProphylaxisPLOS ONE 2016; 11(5): e0155020 doi: 10.1371/journal.pone.0155020
12
Minh T. Hong, Leslie C. Monye, Charles F. Seifert. Acid Suppressive Therapy for Stress Ulcer Prophylaxis in Noncritically Ill PatientsAnnals of Pharmacotherapy 2015; 49(9): 1004 doi: 10.1177/1060028015592014
13
M.S. Mohamad, N. Shamsuddin, K.M. Tan. Appropriateness of stress ulcer prophylaxis among older adults admitted to general medical wards in a university hospitalEuropean Geriatric Medicine 2015; 6(2): 119 doi: 10.1016/j.eurger.2014.11.004